Assessing Cardiovascular Risk: Where Are the Data Now and Where Do We Go From Here?

Explore health disparities, risk factors, and assessment techniques.

Member Cost: $0Non-member Cost: $0
Credits: 1.0 CE contact hours, 0.0 CE pharmacology hours

Course Overview

Learn the role of CVD risk assessment as part of guidelines-directed therapy from Dr. Donald Lloyd-Jones. This 1.0 CE contact hour course covers risk factors from health disparities and emerging CV risk assessment techniques that may complement the current model of risk assessment, including when to consider screening for elevated Lp (a) and the Coronary Artery Calcium (CAC) score.

Member Cost: $0Non-member Cost: $0
Credits: 1.0 CE contact hours, 0.0 CE pharmacology hours

Register

Learning Objectives

1. Explain the role of CV risk assessment as part of guidelines-directed therapy.
2. Discuss health disparities associated with CV risk assessment.
3. Describe risk-enhancing factors to take into consideration and when to consider screening for elevated Lp (a) and Coronary Artery Calcium (CAC) score
4. Review any emerging CV risk assessment techniques that may complement the current model of risk assessment.

Faculty

  • Donald Lloyd-Jones, MD ScM FACC FAHA
Full_Color_Provider

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.